wakatuki masaru

FacultyHospitalRadiologyService
Job titleProfessorWeb site

Profile

Research Areas

  • Clinical internal medicine / Radiation science

Academic Societies

  • JAPAN SOCIETY OF CLINICAL ONCOLOGY
  • JAPAN SOCIETY OF GYNECOLOGIC ONCOLOGY
  • JAPAN RADIOLOGICAL SOCIETY
  • JAPANESE SOCIETY FOR RADIATION ONCOLOGY
Display all
Academic Societiesclose
  • JAPAN SOCIETY OF CLINICAL ONCOLOGY
  • JAPAN SOCIETY OF GYNECOLOGIC ONCOLOGY
  • JAPAN RADIOLOGICAL SOCIETY
  • JAPANESE SOCIETY FOR RADIATION ONCOLOGY

Research Activities

Papers(paper)

  • The prognostic value of rectal invasion for stage IVA uterine cervical cancer treated with radiation therapy.
    Wakatsuki M, Kato S, Kiyohara H, Ohno T, Karasawa K, Tamaki T, Ando K, Shiba S, Kamada T, Nakano T
    BMC cancer 16(1) 244 Mar. 2016
  • Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel in patients with locally advanced uterine cervical cancer: The JACCRO GY-01 trial.
    Umayahara K, Takekuma M, Hirashima Y, Noda SE, Ohno T, Miyagi E, Hirahara F, Hirata E, Kondo E, Tabata T, Nagai Y, Aoki Y, Wakatsuki M, Takeuchi M, Toita T, Takeshima N, Takizawa K
    Gynecologic oncology 140(2) 253-258 Feb. 2016
  • Concurrent chemoradiotherapy for T3-4 and N0-1 nasopharyngeal cancer: Asian multicenter trial of the Forum for Nuclear Cooperation in Asia.
    Ohno T, Wakatsuki M, Thinh DH, Tung NT, Erawati D, Supriana N, Beena Devi CR, Kato S, Thephamongkhol K, Chansilpa Y, Calaguas MJ, Xiaoting X, Jianping C, Banu PA, Cho CK, Karasawa K, Nakano T, Tsujii H
    Journal of radiation research 57(1) 44-49 Jan. 2016
  • Difference in distant failure site between locally advanced squamous cell carcinoma and adenocarcinoma of the uterine cervix after C-ion RT.
    Wakatsuki M, Kato S, Ohno T, Kiyohara H, Karasawa K, Tamaki T, Ando K, Irie D, Shiba S, Tsujii H, Nakano T, Kamada T, Shozu M, Working Group of the Gynecological Tumor
    Journal of radiation research 56(3) 523-528 May 2015
  • Clinical trial of prophylactic extended-field carbon-ion radiotherapy for locally advanced uterine cervical cancer (protocol 0508).
    Wakatsuki M, Kato S, Kiyohara H, Ohno T, Karasawa K, Tamaki T, Ando K, Tsujii H, Nakano T, Kamada T, Shozu M, Working Group of the Gynecological Tumor
    PloS one 10(5) e0127587 2015
  • Correction: Clinical Trial of Prophylactic Extended-Field Carbon-Ion Radiotherapy for Locally Advanced Uterine Cervical Cancer (Protocol 0508).
    Wakatsuki M, Kato S, Kiyohara H, Ohno T, Karasawa K, Tamaki T, Ando K, Tsujii H, Nakano T, Kamada T, Shozu M, Working Group of the Gynecological Tumor
    PloS one 10(11) e0143301 2015
  • Clinical outcomes of carbon ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix in phase 1/2 clinical trial (protocol 9704).
    Wakatsuki M, Kato S, Ohno T, Karasawa K, Kiyohara H, Tamaki T, Ando K, Tsujii H, Nakano T, Kamada T, Shozu M, Working Group of the Gynecological Tumor
    Cancer 120(11) 1663-1669 Jun. 2014
  • Health-related quality of life after carbon-ion radiotherapy for prostate cancer: a 3-year prospective study.
    Katoh H, Tsuji H, Ishikawa H, Kamada T, Wakatsuki M, Hirasawa N, Suzuki H, Akakura K, Nakano T, Shimazaki J, Tsujii H
    International journal of urology : official journal of the Japanese Urological Association 21(4) 370-375 Apr. 2014
  • Impact of boost irradiation on pelvic lymph node control in patients with cervical cancer.
    Wakatsuki M, Ohno T, Kato S, Ando K, Noda SE, Kiyohara H, Shibuya K, Karasawa K, Kamada T, Nakano T
    Journal of radiation research 55(1) 139-145 Jan. 2014
  • Dose-escalation study of carbon ion radiotherapy for locally advanced squamous cell carcinoma of the uterine cervix (9902).
    Wakatsuki M, Kato S, Ohno T, Karasawa K, Ando K, Kiyohara H, Tsujii H, Nakano T, Kamada T, Shozu M, Working Group of the Gynecological Tumor
    Gynecologic oncology 132(1) 87-92 Jan. 2014
Display all
Papers(paper)close
  • The prognostic value of rectal invasion for stage IVA uterine cervical cancer treated with radiation therapy.
    Wakatsuki M, Kato S, Kiyohara H, Ohno T, Karasawa K, Tamaki T, Ando K, Shiba S, Kamada T, Nakano T
    BMC cancer 16(1) 244 Mar. 2016
  • Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel in patients with locally advanced uterine cervical cancer: The JACCRO GY-01 trial.
    Umayahara K, Takekuma M, Hirashima Y, Noda SE, Ohno T, Miyagi E, Hirahara F, Hirata E, Kondo E, Tabata T, Nagai Y, Aoki Y, Wakatsuki M, Takeuchi M, Toita T, Takeshima N, Takizawa K
    Gynecologic oncology 140(2) 253-258 Feb. 2016
  • Concurrent chemoradiotherapy for T3-4 and N0-1 nasopharyngeal cancer: Asian multicenter trial of the Forum for Nuclear Cooperation in Asia.
    Ohno T, Wakatsuki M, Thinh DH, Tung NT, Erawati D, Supriana N, Beena Devi CR, Kato S, Thephamongkhol K, Chansilpa Y, Calaguas MJ, Xiaoting X, Jianping C, Banu PA, Cho CK, Karasawa K, Nakano T, Tsujii H
    Journal of radiation research 57(1) 44-49 Jan. 2016
  • Difference in distant failure site between locally advanced squamous cell carcinoma and adenocarcinoma of the uterine cervix after C-ion RT.
    Wakatsuki M, Kato S, Ohno T, Kiyohara H, Karasawa K, Tamaki T, Ando K, Irie D, Shiba S, Tsujii H, Nakano T, Kamada T, Shozu M, Working Group of the Gynecological Tumor
    Journal of radiation research 56(3) 523-528 May 2015
  • Clinical trial of prophylactic extended-field carbon-ion radiotherapy for locally advanced uterine cervical cancer (protocol 0508).
    Wakatsuki M, Kato S, Kiyohara H, Ohno T, Karasawa K, Tamaki T, Ando K, Tsujii H, Nakano T, Kamada T, Shozu M, Working Group of the Gynecological Tumor
    PloS one 10(5) e0127587 2015
  • Correction: Clinical Trial of Prophylactic Extended-Field Carbon-Ion Radiotherapy for Locally Advanced Uterine Cervical Cancer (Protocol 0508).
    Wakatsuki M, Kato S, Kiyohara H, Ohno T, Karasawa K, Tamaki T, Ando K, Tsujii H, Nakano T, Kamada T, Shozu M, Working Group of the Gynecological Tumor
    PloS one 10(11) e0143301 2015
  • Clinical outcomes of carbon ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix in phase 1/2 clinical trial (protocol 9704).
    Wakatsuki M, Kato S, Ohno T, Karasawa K, Kiyohara H, Tamaki T, Ando K, Tsujii H, Nakano T, Kamada T, Shozu M, Working Group of the Gynecological Tumor
    Cancer 120(11) 1663-1669 Jun. 2014
  • Health-related quality of life after carbon-ion radiotherapy for prostate cancer: a 3-year prospective study.
    Katoh H, Tsuji H, Ishikawa H, Kamada T, Wakatsuki M, Hirasawa N, Suzuki H, Akakura K, Nakano T, Shimazaki J, Tsujii H
    International journal of urology : official journal of the Japanese Urological Association 21(4) 370-375 Apr. 2014
  • Impact of boost irradiation on pelvic lymph node control in patients with cervical cancer.
    Wakatsuki M, Ohno T, Kato S, Ando K, Noda SE, Kiyohara H, Shibuya K, Karasawa K, Kamada T, Nakano T
    Journal of radiation research 55(1) 139-145 Jan. 2014
  • Dose-escalation study of carbon ion radiotherapy for locally advanced squamous cell carcinoma of the uterine cervix (9902).
    Wakatsuki M, Kato S, Ohno T, Karasawa K, Ando K, Kiyohara H, Tsujii H, Nakano T, Kamada T, Shozu M, Working Group of the Gynecological Tumor
    Gynecologic oncology 132(1) 87-92 Jan. 2014
  • Interfractional change of high-risk CTV D90 during image-guided brachytherapy for uterine cervical cancer.
    Ohkubo Y, Ohno T, Noda SE, Kubo N, Nakagawa A, Kawahara M, Abe T, Kiyohara H, Wakatsuki M, Nakano T
    Journal of radiation research 54(6) 1138-1145 Nov. 2013
  • Upregulated expression of FGF13/FHF2 mediates resistance to platinum drugs in cervical cancer cells.
    Okada T, Murata K, Hirose R, Matsuda C, Komatsu T, Ikekita M, Nakawatari M, Nakayama F, Wakatsuki M, Ohno T, Kato S, Imai T, Imamura T
    Scientific reports 3 2899 Oct. 2013
  • Carbon-ion radiotherapy for marginal lymph node recurrences of cervical cancer after definitive radiotherapy: a case report.
    Tamaki T, Ohno T, Kiyohara H, Noda SE, Ohkubo Y, Ando K, Wakatsuki M, Kato S, Kamada T, Nakano T
    Radiation oncology (London, England) 8 79 Apr. 2013
  • Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancer.
    Harada K, Ishikawa H, Saito Y, Nakamoto S, Kawamura H, Wakatsuki M, Etsunaga T, Takezawa Y, Kobayashi M, Nakano T
    Journal of radiation research 53(6) 923-929 Nov. 2012
  • Differential bystander signaling between radioresistant chondrosarcoma cells and fibroblasts after x-ray, proton, iron ion and carbon ion exposures.
    Wakatsuki M, Magpayo N, Kawamura H, Held KD
    International journal of radiation oncology, biology, physics 84(1) e103-8 Sep. 2012
  • Intracavitary combined with CT-guided interstitial brachytherapy for locally advanced uterine cervical cancer: introduction of the technique and a case presentation.
    Wakatsuki M, Ohno T, Yoshida D, Noda SE, Saitoh J, Shibuya K, Katoh H, Suzuki Y, Takahashi T, Nakano T
    Journal of radiation research 52(1) 54-58 2011
  • High-dose-rate interstitial brachytherapy with computed tomography-based treatment planning for patients with locally advanced uterine cervical carcinoma.
    Saitoh J, Ohno T, Sakurai H, Katoh H, Wakatsuki M, Noda SE, Suzuki Y, Sibuya K, Takahashi T, Nakano T
    Journal of radiation research 52(4) 490-495 2011
  • Influence of histological subtype on survival after combined therapy of surgery and radiation in WHO grade 3 glioma.
    Shirai K, Suzuki Y, Okamoto M, Wakatsuki M, Noda SE, Takahashi T, Ishiuchi S, Hasegawa M, Nakazato Y, Nakano T
    Journal of radiation research 51(5) 589-594 2010
  • The benefit of small bowel and pelvic bone sparing in excluding common iliac lymph node region from conventional radiation fields in patients with uterine cervical cancer: a dosimetric study.
    Oike T, Ohno T, Wakatsuki M, Noda SE, Saitoh J, Mizukami T, Yoshimoto Y, Okonogi N, Katoh H, Shibuya K, Suzuki Y, Ishikawa H, Ebara T, Takahashi T, Nakano T
    Journal of radiation research 51(6) 715-721 2010
  • Inoperable Pancoast tumors treated with hyperthermia-inclusive multimodality therapies.
    Ebara T, Sakurai H, Wakatsuki M, Nonaka T, Ishikawa H, Kawamura H, Yoshida D, Shioya M, Nakayama Y, Nakano T
    Lung cancer (Amsterdam, Netherlands) 63(2) 247-250 Feb. 2009
  • Quality of life in men treated with carbon ion therapy for prostate cancer.
    Wakatsuki M, Tsuji H, Ishikawa H, Yanagi T, Kamada T, Nakano T, Suzuki H, Akakura K, Shimazaki J, Tsujii H
    International journal of radiation oncology, biology, physics 72(4) 1010-1015 Nov. 2008
  • Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
    Yoshimura R, Hayashi K, Ayukawa F, Toda K, Iwata M, Oota S, Hoshi A, Wakatsuki M, Kurosaki H, Okazaki A, Shibuya H
    Brachytherapy 7(3) 260-266 Jul. 2008
  • p73 protein expression correlates with radiation-induced apoptosis in the lack of p53 response to radiation therapy for cervical cancer.
    Wakatsuki M, Ohno T, Iwakawa M, Ishikawa H, Noda S, Ohta T, Kato S, Tsujii H, Imai T, Nakano T
    International journal of radiation oncology, biology, physics 70(4) 1189-1194 Mar. 2008
  • Late rectal complications evaluated by computed tomography-based dose calculations in patients with cervical carcinoma undergoing high-dose-rate brachytherapy.
    Noda SE, Ohno T, Kato S, Ishii T, Saito O, Wakatsuki M, Tamaki T, Watanabe K, Nakano T, Tsujii H
    International journal of radiation oncology, biology, physics 69(1) 118-124 Sep. 2007
  • Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy.
    Wakatsuki M, Suzuki Y, Nakamoto S, Ohno T, Ishikawa H, Kiyohara H, Kiyozuka M, Shirai K, Nakayama Y, Nakano T
    Journal of gastroenterology and hepatology 22(5) 715-719 May 2007
  • Cyclooxygenase-2 impairs treatment effects of radiotherapy for cervical cancer by inhibition of radiation-induced apoptosis.
    Ishikawa H, Ohno T, Kato S, Wakatsuki M, Iwakawa M, Ohta T, Imai T, Mitsuhashi N, Noda SE, Nakano T, Tsujii H
    International journal of radiation oncology, biology, physics 66(5) 1347-1355 Dec. 2006
  • Incidence and temporal pattern of anorexia, diarrhea, weight loss, and leukopenia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin: comparison with radiation therapy alone.
    Ohno T, Kato S, Wakatsuki M, Noda SE, Murakami C, Nakamura M, Tsujii H
    Gynecologic oncology 103(1) 94-99 Oct. 2006
  • Carbon ion radiation therapy for prostate cancer: results of a prospective phase II study.
    Ishikawa H, Tsuji H, Kamada T, Yanagi T, Mizoe JE, Kanai T, Morita S, Wakatsuki M, Shimazaki J, Tsujii H, Working Group for Genitourinary Tumors
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 81(1) 57-64 Oct. 2006


Copyright c MEDIA FUSION Co.,Ltd. All rights reserved.